EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Effect of human platelet-rich fibrin lysate on collagen type I, collagen type III, and matrix metalloproteinase 1: a protocol study on rat models with pelvic organ prolapse

Akbar Novan Dwi Saputra iD, Dicky Moch Rizal iD, Nandia Septiyorini, Muhammad Nurhadi Rahman, Yohanes Widodo Wirohadidjojo, Dwi Cahyani Ratna Sari iD, Raden Mas Sonny Sasotya

F1000Research · 16.09.2025 · 13 · 1056

DOI: 10.12688/f1000research.152876.2 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift F1000Research, online erschienen am 16.09.2025. Verfasst von Akbar Novan Dwi Saputra und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine, Public Health and Nursing, Dr. Sardjito Hospital, Universitas Gadjah Mada, Yogyakarta, …. Hauptthemen laut MEDLINE: Pelvic Organ Prolapse, Collagen Type I, Collagen Type III, Platelet-Rich Fibrin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitas Gadjah Mada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pelvic organ prolapse (POP) is a prevalent condition caused by weakened pelvic floor support structures. Extracellular matrix alterations, including changes in collagen type I, collagen type III, and matrix metalloproteinase 1 (MMP-1), contribute to the pathogenesis of this condition. Human platelet-rich fibrin lysate (hPRF-L) is a novel regenerative treatment that has shown beneficial results in treating structural weaknesses related to various pelvic floor diseases, including POP.

Methods

This study protocol aims to investigate the effects of hPRF-L injection on collagen I, III, and MMP-1 in the vaginal mucosa of a rat POP model. POP will be induced in female Sprague-Dawley rats, which will be randomly assigned to control, sham, and hPRF-L treatment groups. The hPRF-L group will receive weekly injections of hPRF-L (25, 50, or 75 μL) into the vaginal mucosa for 4 weeks. Vaginal tissue samples will be collected, and collagen type I, collagen type III, and MMP-1 expression will be evaluated using quantitative reverse transcription polymerase chain reaction and immunohistochemical analyses. Data analysis will be performed with ANOVA and post-hoc tests.

Discussion

The findings from this study protocol are expected to provide valuable insights into the mechanisms by which hPRF-L impacts the structural integrity of the pelvic floor. By elucidating these mechanisms, this study aims to inform future POP treatment strategies. The anticipated results are an increase in collagen type I and III expression and a reduction in MMP-1 levels in the hPRF-L treatment group compared to the control and sham groups. These outcomes could support the use of hPRF-L as a regenerative therapy for managing POP, offering a potential alternative to more invasive surgical interventions.

Conclusion

The expected results will contribute to the development of less invasive treatments for POP, improving patient outcomes and quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pelvic Organ ProlapseCollagen Type ICollagen Type IIIPlatelet-Rich FibrinMatrix Metalloproteinase 1AnimalsFemaleRats, Sprague-DawleyHumansDisease Models, AnimalRatsVagina

Stichwörter der Autor:innen

Pelvic organ prolapsecollagen type Icollagen type IIIextracellular matrixhuman platelet-rich fibrin lysatematrix metalloproteinase 1protocol study

Substanzen

Collagen Type ICollagen Type IIIMatrix Metalloproteinase 1

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Faculty of Medicine, Public Health and Nursing, Dr. Sardjito Hospital, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, 55281, Indonesia.
  • Doctoral Program, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, 55281, Indonesia.
  • Department of Physiology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, 55281, Indonesia.
  • Department of Dermatovenerology, Faculty of Medicine, Public Health and Nursing, Dr. Sardjito Hospital, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, 55281, Indonesia.
  • Department of Anatomy, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, 55281, Indonesia.
  • Urogynecology and Reconstruction Division, Obstetrics and Gynecology Department, Faculty of Medicine, Universitas Padjadjaran, Bandung, West Java, 45363, Indonesia.

ORCID-Profile: Akbar Novan Dwi Saputra, Dicky Moch Rizal, Dwi Cahyani Ratna Sari

Förderung

  • Universitas Gadjah Mada

Zitieren

APA

Saputra, A. N. D., Rizal, D. M., Septiyorini, N., Rahman, M. N., Wirohadidjojo, Y. W., Sari, D. C. R., & Sasotya, R. M. S. (2025). Effect of human platelet-rich fibrin lysate on collagen type I, collagen type III, and matrix metalloproteinase 1: a protocol study on rat models with pelvic organ prolapse. F1000Research, 13, 1056. https://doi.org/10.12688/f1000research.152876.2

Vancouver

Saputra AND, Rizal DM, Septiyorini N, Rahman MN, Wirohadidjojo YW, Sari DCR, et al. Effect of human platelet-rich fibrin lysate on collagen type I, collagen type III, and matrix metalloproteinase 1: a protocol study on rat models with pelvic organ prolapse. F1000Research. 2025;13:1056. doi:10.12688/f1000research.152876.2

BibTeX
@article{Saputra2025,
  author = {Saputra, Akbar Novan Dwi and Rizal, Dicky Moch and Septiyorini, Nandia and Rahman, Muhammad Nurhadi and Wirohadidjojo, Yohanes Widodo and Sari, Dwi Cahyani Ratna and Sasotya, Raden Mas Sonny},
  title = {Effect of human platelet-rich fibrin lysate on collagen type I, collagen type III, and matrix metalloproteinase 1: a protocol study on rat models with pelvic organ prolapse},
  journal = {F1000Research},
  year = {2025},
  volume = {13},
  pages = {1056},
  doi = {10.12688/f1000research.152876.2}
}
Kostenlos starten →